Rejection is never pleasant. But for the 34,459 patients whose health plans refuse to cover advanced treatment for high cholesterol, it could also be deadly.
Promising clinical trials data has excited patients with cystic fibrosis and their families. But will access barriers dash their hopes for more and better treatment
What is good value in terms of cancer treatment? The question, amid rising cancer care costs, has prompted a surge of oncology value models in
Physicians and patients are no longer asking if a biological medicine is the best choice, but – more likely – which biological medicine is the
First came biologics, then biosimilars. And soon, explains a newly released video from The Alliance for Patient Access, patients can expect interchangeable biosimilars. According to
A drug pricing watchdog group had its final say Friday on targeted arthritis treatments – and it may not be good news for patients. The
A vaccine for Zika virus is in the works with the potential to halt the devastating disease that’s spread to more than 5,000 people and